This page has moved. Click here to view. Acute Lukemia Acute lukemia is a hematopoietic progenitor cell malignancy. These cells proliferate in an uncontrolled fashion and ultimately replace normal bone marrow elements.
Most cases arise with no clear cause.
The peak incidence is between 3 and 7 years of age. Most patients with acute leukemia present with an acute illness and have been ill only for days or weeks. Less commonly, widespread severe bleeding is seen in Treatment Most young patients with acute leukemia are treated with the objective of effecting a cure. The first step in treatment is to obtain complete remission, defined as Acute myelogenous lukemia is treated initially with intensive combination chemotherapy, including daunorubicin and cytarabine. Effective treatment produces aplasia of the bone marrow, which takes 2 B 3 weeks to recover.